Bellalgin

Contraindications

Hypersensitivity (including to certain components), glaucoma, prostate adenoma.

Undesirable effects

Dry mouth, thirst, constipation, drowsiness, dizziness, mydriasis (dilated pupils).

Special instructions

It is not recommended to assign (without exemption from work) to transport drivers.

Therapeutic indications

Diseases of the gastrointestinal tract, accompanied by hyperacidity of gastric juice, spasms of smooth muscles, pain.

Pharmacotherapeutic group

  • m-Cholinolytics in combinations

Pharmacodynamic properties

The action is determined by the effects of the components that are included in the composition. Antispasmodic (lowering the tone of smooth muscle organs, including the gastrointestinal tract) and antisecretory effects (reducing the secretion of gastric, pancreatic, bronchial, salivary, sweat glands and bile secretion) are due to the alkaloids of the extract of belladonna (hyoscyamine, scopolamine, apoatropin, etc.), analgesic — metamizole and anesthesin, antacid — sodium bicarbonate.

Special precautions for storage

In a dry, dark place.

Keep out of reach of children.

Shelf life of the drug Bellalgin3 года.

Do not use after the expiration date indicated on the package.

Instructions for medical use


Instructions for medical use-RU no.

Last modified date: 24.01.2017

Composition

1 tablet contains:

Active ingredients: metamizole sodium (analgin) - 250 mg, benzocaine (anesthesin) - 250 mg, sodium bicarbonate-100 mg, belladonna extract thick-15 mg.

Excipients: potato starch-42.16 mg, sodium carboxymethyl starch-33 mg, colloidal silicon dioxide (aerosil) - 14 mg, talc-7.2 mg, calcium stearate -7.2 mg, polysorbate (twin-80) - 1.44 mg.

Composition and form of release

pills

Description of the dosage form

Tablets from light yellow to yellowish-gray color with darker inclusions, round, flat-cylindrical shape with a chamfer and a risk.

Pharmacological Group

analgesic non-narcotic (analgesic non-narcotic local anesthetic) and antispasmodic

Pharmacological (immuno-biological) properties

The combined drug has antispasmodic, antacid, local anesthetic and analgesic effects.

Indications

As a symptomatic remedy for diseases of the gastrointestinal tract, accompanied by increased secretory function of the stomach and spasms of smooth muscles in order to relieve heartburn, belching, pain syndrome (hyperacid gastritis, gastric ulcer and duodenal ulcer).

Contraindications

Contraindications

Angle-closure glaucoma, prostatic hyperplasia, severe kidney and/or liver disorders, glucose-6-phosphate dehydrogenase deficiency, hematopoietic depression (anemia, granulocytopenia, leukopenia, agranulocytosis, cytostatic or infectious neutropenia), "aspirin" asthma, pregnancy (especially in the first trimester and in the last 6 weeks), lactation, children under 6 years of age, hypersensitivity to the components of the drug.

With caution - kidney diseases, (pyelonephritis, glomerulonephritis, including in the anamnesis), long-term alcohol abuse.

Method of administration and dosage

Inside, before eating. Adults: 1 tablet 2-3 times a day. The highest single dose is 2 tablets, the daily dose is 5 tablets.

Children over b years of age: as prescribed by a doctor, usually 1/2 tablet 1-2 times a day.

Side effects

From the urinary system: impaired renal function, oliguria, anuria, proteinuria, interstitial nephritis, urine staining in red.

Allergic reactions: urticaria, (including on the conjunctiva and mucous membranes of the nasopharynx), angioedema, in rare cases, malignant exudative erythema (Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell's syndrome), bronchospastic syndrome, anaphylactic shock.

From the side of the hematopoietic organs: agranulocytosis, leukopenia, thrombocytopenia.

Other: decreased blood pressure, dry mouth, thirst, constipation, mydriasis, paresis of accommodation, temporary visual impairment, dysuria, urinary retention, palpitations, drowsiness, dizziness, psychomotor agitation, convulsions.

Interaction

Increases the effects of ethanol, concomitant use with chlorpromazine or other phenothiazine derivatives can lead to the development of severe hyperthermia.

Radiopaque agents, colloidal blood substitutes and penicillin should not be used during treatment with metamizole.

With the simultaneous administration of cyclosporine, the concentration of the latter in the blood decreases.

Metamizole, displacing oral hypocycemic drugs, indirect anticoagulants, glucocorticosteroids and indomethacin from the protein bond, increases their activity.

Phenylbutazone, barbiturates and other heatinduced while the appointment decrease efficacy of metamizol.

Concomitant administration with other non-narcotic analgesics, tricyclic antidepressants, hormonal contraceptives, and allopurinol may lead to increased toxicity. Sedative and anxiolytic drugs (tranquilizers) enhance the analgesic effect Metamizole.

Thiamazole and cytostatics increase the risk of developing leukopenia.

The effect is enhanced by codeine, N2- histamine blockers and propranolol (slows down inactivation).

Special instructions

Patients with atopic bronchial asthma and pollinosis have an increased risk of developing allergic reactions.

Against the background of taking metamizole sodium, agranulocytosis may develop, and therefore, if an unmotivated rise in temperature, chills, sore throat, difficulty swallowing, stomatitis, as well as the development of vaginitis or proctitis, immediate withdrawal of the drug is necessary. With prolonged use, it is necessary to monitor the picture of peripheral blood.

It is unacceptable to use it to relieve acute abdominal pain (until the cause is clarified).

Against the background of the application, it is possible to stain the urine red due to the release of the metabolite.

Do not use the drug when driving vehicles and during work that requires a high rate of psychomotor reactions.

Release form

Pills. 10 tablets in a contour cell package.

1, 2 or 3 contour cell packages together with the instructions for use are placed in a pack of cardboard.

It is allowed to place contour cell packages together with an equal number of instructions for use directly in a group package.

Storage conditions

In a place protected from light, at a temperature not exceeding 25 °C.

Keep out of reach of children.

Expiration date

3 years. Do not use after the expiration date indicated on the package.

Conditions of supply of pharmacies

Available without a prescription.

Беллалгин - инструкция по медицинскому применению - РУ № ЛС-002453 от 2011-10-31
Беллалгин - инструкция по медицинскому применению - РУ № Р N000833/01 от 2014-11-17

Nature and contents of container

1 tablet contains extract of belladonna thick 0.015 g, analgin and anesthesin 0.25 g each and sodium bicarbonate 0.1 g, in a package of 10 pcs.

Nosological classification (ICD-10)

  • K25 Stomach ulcer
  • K26 Duodenal ulcer
  • K29 Gastritis and duodenitis
  • K31 Other diseases of the stomach and duodenum
  • K31. 3 Pylorospasm, not classified elsewhere
  • K81 Cholecystitis
  • R10. 1 Pain localized in the upper abdomen
  • R10. 4 Other and unspecified abdominal pain

Dosage (Posology) and method of administration

Inside, before meals-1 table. 2-3 times a day. The highest single dose for adults is 3 tablets, the daily dose is 10 tablets. The course of treatment — as needed (mandatory doctor's recommendation).

ATC - Anatomical and therapeutic chemical classification

A03DB Belladonna and its derivatives in combination with analgesics